Showing results (1191-1200 of 1,246) with videos related to

Sort By:
Pageof 125
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic CellsGerty Schreibelt, Kalijn F Bol, Harm Westdorp, et al.
The New England Journal of Medicine|December 12, 2023
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple MyelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Future Oncology (London, England)|September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Nature Communications|February 23, 2024
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trialKalijn F Bol, Gerty Schreibelt, Martine Bloemendal, et al.
Physical Review Letters|August 25, 2023
Evidence for Modification of b Quark Hadronization in High-Multiplicity pp Collisions at sqrt[s]=13 TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|August 11, 2023
Nuclear Modification Factor of Neutral Pions in the Forward and Backward Regions in p-Pb CollisionsR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|September 22, 2023
Measurement of the Prompt D^{0} Nuclear Modification Factor in p-Pb Collisions at sqrt[s_{NN}]=8.16 TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Physical Review Letters|March 22, 2024
Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16 TeVR Aaij, A S W Abdelmotteleb, C Abellan Beteta, et al.
Pageof 125